Search
Print Page   |   Contact Us   |   Sign In   |   Join Today
VABIO E-News August 27, 2015
Share |



Become a Member



VABIO E-News: August 27, 2015 Edition

Focus Around Virginia
A Word from CEO Jeff Gallagher

Members and friends of Virginia Bio,

On Wednesday, September 9, we are helping to mount the Governor’s Conference on Agricultural and Industrial Bio, in Danville at the impressive Institute for Advanced Learning and Research.

For the first time ever in Virginia, we’ll gather the companies, researchers and members of the agricultural community working in this rapidly growing high value sector where hi-tech meets Virginia’s largest private industry.

Agricultural and Industrial biotechnology is enabling the world to feed its growing populations and supply fuel and materials to its growing economies in an affordable, sustainable and environmentally sound manner. At the end of this letter, I provide a snapshot of field for those who are unaware.

This rapidly growing sector provides an opportunity to add new hi-tech strength to a pillar of Virginia’s economy. In turn this will strengthen the state’s traditional biomedical biotech industry because of the commonality of skills, talents, resources, supplies, equipment and services required to succeed in R&D and commercialization.
Thanks to generous sponsors, the event is free of charge.

It’s a great agenda on September 9, which will enable attendees to learn in one day, in one place what’s going on in the industry in Virginia, to meet the key players, to better understand the opportunities, to assess public policy and start to think about moving forward.

For complete article click here.


Thank you to our Premium Partners

PLATINUM PARTNERS
:



Gold Partners:


Silver Partners:


In this issue
focus around Virginia
VABIO Articles
VABIO Community News
VABIO Anniversaries
VABIO Calendar

VABIO News

MEMBERS GET FREE INVESTMENT DATA
SONTHEIMER NAMED VT CHAIR
ORAGENICS AND INTREXON STUDY
VA LEADERS PITCH 'GO VIRGINIA'
2015 GLOBAL RPPA WORKSHOP
STEGER JOINS FOUNDATION COUNCIL
OXFORD CLOSES $15M DEBT FACILITY
LIGHTHOUSE LABS WINS SBA GRANT
VIRGINIA VELOCITY NAMES FINALISTS
REVIVICOR ORGANS SET RECORDS
AMPLIPHI APPROVED FOR NYSE MKT
DOD AWARDS LEIDOS $4.3B CONTRACT
SMV OPENS AWARD NOMINATIONS
PEDIATRIC DEVICE COMPETITION
MEDICAL PRODUCT R&D AWARD
WELCOME Coeurative, Inc.
WELCOME NTI
WELCOME ViGYAN
VABIO Community News
VABIO Member Anniversaries

VABIO Events
Virginia Bio Calendar

 
 
 
 
 
 
 
 



 
 
 
 
 
 
 
 

VABIO Articles TO TOP

Bioscience Company Members Now Get Free Access to Investment Deals and Investors

Virginia Bio has entered into a one year agreement with CB Insights to arrange for complimentary access for our bioscience company members to CB Insight’s proprietary comprehensive database of private investment data on current and historic deals and investors.

For complete article click here.

Virginia Tech’s Harald Sontheimer to hold I. D. Wilson Chair in the College of Science

Harald Sontheimer, who joined Virginia Tech earlier this month to direct a university-wide neuroscience initiative, will hold the I. D. Wilson Chair in the College of Science. That appointment was recently approved by the Virginia Tech Board of Visitors.

For complete article click here.


Oragenics and Intrexon Report Positive In Vivo Antibiotic Efficacy Data in Critical Animal Study


Oragenics, Inc. and Intrexon Corporation, a leader in synthetic biology, announced today positive data on multiple compounds from Oragenics’ Mutacin 1140 ("MU1140”) lantibiotic platform in a critical animal model study, as well as the selection of a lead clinical candidate. The compounds were subjected to a standardized "proof of concept” animal model evaluating efficacy for reducing clinically relevantC. difficile infection(s) and increased survival relative to vancomycin positive control.

For complete article click here.

Also, Intrexon closed its previously announced public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 731,707 shares of common stock at the public offering price of $41.00 per share. The exercise of the underwriters' option brought the total number of shares of common stock sold by Intrexon to 5,609,756 shares and increased the total gross proceeds raised in the offering to approximately $230 million, before deducting the underwriting discounts, commissions, and estimated expenses.

For complete article click here.

VA Leaders Pitch 'Go Virginia' Plan for New State Incentives

As reported by the Associated Press, corporate titans, university heads and top elected leaders unveiled a new initiative called "Go Virginia” at recent news conferences around the state.

Organizers said that more specifics are forthcoming in future months - but its main thrust is that Virginia’s economy is better served when localities in a specific regions work together rather than on their own or even against one another.

For complete article click here.

Call For Abstracts Due Sept 1 – 2015 Global Reverse Phase Protein Array Workshop

The 5th annual RPPA Global Workshop will be hosted at George Mason University, Manassas, Virginia on October 12-13, 2015.

Join top industry, academic, and government leaders as they present and discuss the RPPA technology’s applications in precision medicine, drug discovery, signal transduction, immunotherapy, infectious disease, regenerative medicine, and other high impact biological and medical fields. Future grant opportunities will be communicated.

For complete article
click here.

Former Virginia Tech President Charles Steger Joins Focused Ultrasound Foundation Council


Focused Ultrasound Foundation is pleased to welcome Charles Steger, former President of Virginia Tech, as the newest member of its Council.

"Throughout my career, I have thrived on creating environments to push the frontiers of knowledge,” says Steger. "I am excited to work with the Foundation as they play a critical role in advancing development of focused ultrasound -- an early-stage technology with incredible potential to transform patient care.”

For complete article click here.


Oxford Finance and Silicon Valley Bank Close $15 Million Debt Facility with AlterG

Oxford Finance LLC (Oxford), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, and Silicon Valley Bank (SVB) closed a credit facility, including a $13.5 million senior secured term loan and a $1.5 million line of credit, with AlterG, Inc. AlterG is a privately held, venture-backed medical device and wellness company that has developed Anti-Gravity Treadmills®, as well as the world’s first intuitive AlterG Bionic Leg™.

For complete article click here.


Lighthouse Labs With The Innovation Council And VCU Innovation Gateway, Wins $50K SBA Grant

Lighthouse Labs, in partnership with The Innovation Council of the Virginia Biotechnology Research Park and the VCU Innovation Gateway, has been selected as a recipient of the U.S. Small Business Administration (SBA) 2nd Annual Growth Accelerator Fund Competition, winning $50,000 to help support the expansion of the Richmond region accelerator. The award was announced Tuesday during the White House Demo Day.

For complete article click here.


Virginia Velocity Competition Names Finalists
The Virginia Velocity business plan competition is overseen by the Office of the Secretary of Commerce and Trade. The competition is a key component of Governor Terry McAuliffe’s efforts to catalyze entrepreneurism in the Commonwealth by focusing the growth sectors of bioscience and energy.

The advancement of applicants to the semi-finalist round was based on the total weighted average of the judges’ scores. Each applicant’s application was reviewed by a panel of three individual judges. Based on the aggregated scores, the top five companies in each sector are considered semi-finalists.

For complete article click here.



Revivicor Produced Organs Set Records with Pig-to-Primate Transplants
As reported online in the MIT Technology Review, U.S. researchers have been shattering records in xenotransplantation, or between-species organ transplants, with the financial aid of a biotechnology executive whose daughter may need a lung transplant.

The researchers say they have kept a pig heart alive in a baboon for 945 days and also reported the longest-ever kidney swap between these species, lasting 136 days. The experiments used organs from pigs "humanized” with the addition of as many as five human genes, a strategy designed to stop organ rejection.

For complete article click here.


AmpliPhi Approved for Common Stock Listing on NYSE MKT
AmpliPhi Biosciences Corporation’s shares of common stock have been approved for listing on the NYSE MKT, subject to continued satisfaction of listing requirements.

For complete article click here.


Department of Defense Awards Leidos $4.3 Billion Contract
Leidos, a national security, health and engineering solutions company, was awarded a prime contract by the Department of Defense (DoD) to provide an off-the-shelf electronic health record solution, integration activities and deployment across the Military Health System.

The contract, known as the Defense Healthcare Management System Modernization (DHMSM) program, is an initiative designed to modernize the military's healthcare system in a meaningful way, enabling patients and clinicians to capture and share health data that can improve the continuity and quality of care for 9.6 million active military, their families, and their beneficiaries.

For complete article click here.


31st Virginia Outstanding Scientist Award – Nominations Due November 6
The Science Museum of Virginia is soliciting nominations for Virginia's Outstanding Scientist Award for 2015. For the past 31 years, this program has honored Virginia scientists who, through their research and commitment to science, have made a significant contribution to basic scientific research that extends the boundaries of any field of science. This contribution should be easily recognizable as a definite advance of knowledge or significant technological development.

For complete article click here.


5th Annual Pediatric Device Innovation Competition Accepting Proposals
The Atlantic Pediatric Device Consortium (APDC) is accepting proposals for its 5th annual Pediatric Device Innovation Competition. This seed grant competition is an opportunity for the scientific and business community including entrepreneurs, clinicians, scientists, businesses, academic researchers and medical and engineering graduate and undergraduate students, to develop and commercialize a pediatric medical device.

For complete article click here.


$500 Million to $900 Million Medical Product Research and Development Award

On July 31, 2015, the Department of Defense awarded a contract to four companies, three of which have ties to Virginia, with a combined value of up to $500 million and a $900 million limit over the next five years.

This award essentially pre-vets the companies to provide the Department of the Army with medical product research and development support in the form of an indefinite delivery indefinite quantity contract.

For complete article click here.


Welcome New Member: Coeurative, Inc.
Led by Dr. John Schmedtje, Coeurative, Inc. is creating curative strategies for cardiovascular diseases related to cellular hypoxia.

For more information contact Dr. Schmedtje.


Welcome New Member: Neurodegeneration Therapeutics, Inc.
Neurodegeneration Therapeutics, Inc. (NTI) is a non-profit medical research company that uses iPSC technology to develop novel drug therapies for degenerative brain diseases. NTI's focus is on "personalized pharmacology" to emphasize treatments for specific individuals as opposed to large groups, which is the traditional paradigm for drug development.

Welcome New Member: ViGYAN, Inc.

ViGYAN, Inc., minority-owned and woman-owned, was established to provide aerospace research and development services to the NASA Langley Research Center (LaRC). Since then business has expanded to include aeronautics R&D; wind energy R&D; scientific, engineering, and business software development; marketing support services; and computer technology support.

Per a recent Army Phase I SBIR, ViGYAN is currently developing a system, TBI-ASAP, to screen persons who may have had a mild traumatic brain injury (mTBI). The system uses high-end data analyses techniques derived from the aerospace industry to evaluate speed signals for mTBI.

For more information please visit their website.

VABIO Community News TO TOP

Joseph Leonelli, Ph.D. has joined ATCC, a global biological materials resource and standards organization, as the Vice President for ATCC Federal Solutions (AFS). In this position, Dr. Leonelli will be responsible for the general management and business growth of AFS programs. Dr. Raymond H. Cypess, President and CEO at ATCC said, "Joe brings deep knowledge and expertise to assess, innovate, and grow our solutions to meet the challenging demands of the federal government sector.” Dr. Leonelli comes to ATCC with 30 years of experience in a variety of federal contract research and development market segments. Prior to joining ATCC, he was the vice president for National Security Systems and Solutions for Engility, where he managed three business units providing systems and software engineering to DOD, DOJ, and Intelligence Community customers. Dr. Leonelli held leadership positions at various entities within the Raytheon Company, Applied Signal Technology, General Dynamics, Battelle, and SRI International. He received a Ph.D. in Inorganic Chemistry from Indiana University. His research and development experience includes chemical and biological warfare agent detection, remote sensing, and the forensic analysis of chemical and biological warfare agents from environmental samples. Dr. Leonelli is active with the National Defense Industrial Association (NDIA), Association of the US Army (AUSA), Armed Forces Communications Electronics Association (AFCEA), and Advanced Technical Intelligence Association (ATIA).

In the last year, the Wife/Husband team at RW Malone MD LLC of Jill Glasspool-Malone PhD and Robert Malone MD, MS have started operating from their new base in Scottsville. The group has played a key leadership role in the development of the "highly promising" (WHO Director General Margaret Chan) VSV-EBOV Ebola vaccine which has been described as "The silver bullet against Ebola" (Borge Brende, Foreign Minister of Norway). Both Jill and Robert have also joined 150 other MD and PhD from around the world in the 12 month Harvard Medical School "Global Clinical Scholars Research Training Program" which focuses on epidemiology, biostatistics, data management, ethics and study design for international clinical research. Robert will soon share the podium with NCI's Jay Berzofsky as a keynote speaker at the November 2-4 conference "Vaccines R&D-2015 Baltimore".

Effective July 1, Bob Armstrong took over as Director for the Sentara Center for Simulation and Immersive Learning at Eastern Virginia Medical School in Norfolk, Virginia.

Kevin Willis was promoted to Assistant Director of Business Development within the United Network for Organ Sharing (UNOS) UNOS Business Services department (formerly Tii Informatix). In his new role, Kevin is responsible for the day-to-day operations of the department and plays a key role in growing UBS’ non-OPTN revenue. Kevin has been employed with UNOS for 12 years and has a wealth of knowledge and expertise he lends to the organization.
VABIO Member Anniversaries TO TOP

Virginia Bio would like to thank our long term members who have recently celebrated their membership anniversaries:

Henrico County Economic Development Authority - 19 YEARS
SCHUELKE BIOMEDICAL/LASER SERVICES, INC. - 19 YEARS
FAIRFAX COUNTY ECONOMIC DEVELOPMENT AUTHORITY - 17 YEARS
COUNTY OF ROANOKE, VIRGINIA ECONOMIC DEVELOPMENT - 14 YEARS
DIFFUSION PHARMACEUTICALS, LLC - 14 YEARS
EYERX RESEARCH, INC. - 14 YEARS
LOUDOUN COUNTY DEPARTMENT OF ECONOMIC DEVELOPMENT - 12 YEARS

Virginia Bio would also like to thank our members renewing for the first time:

DATA BLUEPRINT

VABIO Calendar TO TOP

SEPTEMBER 9
Event: Governor’s Agriculture and Industrial Biotechnology Conference
Where: The Institute for Advanced Learning and Research (IALR), Danville, VA
When: Wednesday, September 9, 8am - 4:15pm
Details: Please join Governor Terry McAuliffe and Secretary of Agriculture and Forestry Todd Haymore to kick off the Virginia Ag Bio Initiative. Hosted by VirginiaBIO, this event will bring together public and private partners representing existing businesses engaged in the ag bio sector, research universities, and marketing and economic development professionals from across Virginia and the surrounding region to steer this effort for domestic and international business development. Attendees will discuss the current state of ag bio in the Commonwealth and identify opportunities for networking, collaboration and business development to support the future of this growing sector.
Registration:Click here to register.

SEPTEMBER 10
Event: Virginia Bio Commercialization Luncheon - September 2015
Where: Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, September 10, 11:30am - 1:30pm
Details: Neuroscience research, therapies and partnerships in Virginia: Forming a new collaborative network to take on the challenge of our generation and those to come.
Virginia and national experts will describe the vast and deep neuroscience research ongoing in Virginia universities, research institutions, health care systems and companies. They will share plans underway for growing a statewide neuroscience collaboration to align and coordinate strengths, to build important infrastructure, to pursue major research funding, to expand existing university-commercial partnerships and to develop new ones. They will describe a statewide three-university research collaboration with a major pharmaceutical company that is preparing to get underway, focused on a devastating neurodegenerative disease – ALS.
Registration:
Click here to register.
Sponsors: Greater Richmond Partnership, VCU Innovation Gateway, We Work For Health and the Virginia Biotechnology Research Park

SEPTEMBER 15
Event: Maximizing the value of CB Insights Webinar
When: Tuesday, September 15, 12pm - 1pm
Details: This webinar will provide a live demonstration and training on the CB Insight database, which is now accessible to bioscience companies that are active members of Virginia Bio. The webinar is complimentary but please complete the registration form.
Registration:Click here to register.

SEPTEMBER 16
Event: RESI (Redefining Early Stage Investment) Boston
Where: The Westin Copley Place, Boston, MA
When: Wednesday, September 16, 7am - 5pm
Details: The RESI Conference is an ongoing conference series that will be establishing a global circuit for early stage life sciences companies to source investors, create relationships, and eventually, get funding. The RESI conference focuses on the diverse breadth of early stage investors that LSN tracks, including Family Offices, Venture Philanthropy Funds, VCs, Angel Groups, Corporate Venture Capital Funds, and more. The RESI Partnering Forum allows fundraising executives to identify and book up to 16 meetings with life science investors who fit their company's technology sector and stage of development. Additionally, through an expansive series of panels and workshops, attendees will have the chance to hear firsthand accounts from investors explaining their current investment mandates and process for identifying and qualifying candidates.
Registration: Virginia Bio Members receive discounted registration, please contact us for details and click here for additional information.

SEPTEMBER 17
Event: American Cancer Society Cancer Action Network Virginia Cancer Research Breakfast
Where: Hilton Garden Inn, Glen Allen, VA
When: Thursday, September 17, 7:30am - 9am
Details: Please join us as we discuss current groundbreaking cancer research in Virginia with special guest speakers.
Registration:Click here for additional information.

SEPTEMBER 25 - 26
Event: LifeNet Health Symposium 2015 - Regenerative Surgery: The Cutting Edge
Where: LifeNet Health, Virginia Beach, VA
When: Friday, September 25 - Saturday, September 26
Details: This specialized one and a half day symposium offers participants the opportunity to connect with highly respected providers and scientists from the fields of transformative therapies, technologies and tools in regenerative, reconstructive or restorative applications.
Registration: VIrginia Bio members receive Virginia Bio members receive a $200 discount on registration. Please contact us for the discount code. Click here to register.

SEPTEMBER 25
Event: MDMA's 8th Annual Medical Technology Executive Forum
Where: Crown Plaza Cabana, Palo Alto, CA
When: Friday, September 25
Details: This must-attend one day interactive forum will bring together more than 150 CEOs and senior executives to discuss the critical issues that affect product commercialization and the common challenges faced by med-tech companies today. Industry experts and government officials will address investment options, FDA reform, reimbursement challenges and much more.
Registration: Virginia Bio Members receive $100 off registration! Please contact us for discount details and click here for additional information.

OCTOBER 5 - 7
Event: AdvaMed 2015
Where: San Diego Convention Center, San Diego, CA
When: Monday, October 5 - Wednesday, October 7
Details: AdvaMed 2015 is the leading MedTech Conference in North America, bringing more than 1,000 companies together in a uniquely multifaceted environment for business development, capital formation, innovative technology showcasing, world-class educational opportunities and networking. An event rich in international flavor and featuring a deep, diverse attendee list that includes influential policy-makers, business executives and media, AdvaMed 2015 seeks to advance industry discussion from key perspectives.
Registration:Click here for additional information.

OCTOBER 7 - 8
Event: Big Data in Clinical Development
Where: Ronald Reagan Building and International Trade Center, Washington, DC
When: Wednesday, October 7 - Thursday, October 8
Details: The Big Data meeting for drug development budget holders - Transforming theory into action, value and competitive advantage - Capitalizing on the promise of real world evidence throughout the clinical development process In the wake of the highly successful launch of the Big Data Leaders Forum in October 2014, Phacilitate received extremely positive feedback that a specific focus on the application of Big Data-derived insights in translational and clinical R&D was a strong feature and differentiator of the event. In 2015, the event is renamed ‘Big Data in Clinical Development’ - a signal of intent to provide even more real-world examples of strategies improving decision-making during this most risky and expensive, but also potentially rewarding stage of the overall drug discovery, development and commercialization process. Attendees will receive unique insights into where the major industry players are placing their bets to ensure Big Data in drug development provides a critical source of competitive advantage for years to come. They will also discover the right questions to ask of Big Data throughout the product lifecycle in order to build a more comprehensive body of real world evidence, and a better prediction of value. Meet the senior leaders representing all of the functions that directly influence - and ultimately make- the decision of how individual pharma, CRO and biotech companies will harness the potential of Big Data to improve their clinical development strategies and results.
Registration: Virginia Bio Members receive 25%off registration! Please contact us for discount details and click here for additional information.

OCTOBER 12
Event: JMU and Shenandoah Valley Biotech Showcase
Where: James Madison University, Harrisonburg, VA
When: Monday, October 12, 10:30am
Details: Please join VirginiaBIO, James Madison University, the Shenandoah Valley Partnership and public and private partners as we highlight education and industry innovations in the biotech arena in the Shenandoah Valley.

This event will bring together businesses engaged in the bio sector, regional research assets and academic partners, marketing and economic development professionals to highlight exciting bio innovations in the Shenandoah Valley and the surrounding region. Attendees will discuss current research and academic offerings related to bio at JMU, Blue Ridge Community College, and other workforce partners, and identify opportunities for networking, collaboration and business development. The day will end with a casual Beer & Biotech event in downtown Harrisonburg.

JMU offers the state’s only undergraduate biotechnology degree, and the Valley is home to leading bio companies making advancements in human and animal health, agricultural and industrial bio, health care delivery and manufacturing. Join us as we learn more about public and private university-based bio assets in this region.
Registration:Click here to register.

OCTOBER 15
Event: Virginia Bio Commercialization Luncheon - October 2015
Where: Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, October 15, 11:30am - 1:30pm
Details: The Catalyst: the first three years. Accomplishments and learnings.
The Virginia Bioscience Health Research Corporation (the "Catalyst”) is an innovative non-profit entity created by the state in recent years to make grants to foster collaboration among two or more Virginia public research universities and industry partner for bioscience R&D leading to commercialization. Nearly a dozen grants have been made to competitively judged projects across the state, and across fields and disciplines. The CEO of the Catalyst and leaders of select collaborations which have received grants will share important research, report on progress, evaluate the impact of this innovative public policy and look to the future.
Registration:Click here for additional information.
Sponsors: Greater Richmond Partnership, VCU Innovation Gateway, We Work For Health and the Virginia Biotechnology Research Park

OCTOBER 20 - 21
Event: Kayo Women’s Private Equity 3rd Annual Conference
Where: Four Seasons Georgetown, Washington, DC
When: Tuesday, October 20 - Wednesday, October 21
Details: Join us for this boutique event gathering the 200 leading women in private equity and venture capital. The event features exclusive networking and unique deal-flow for investors, M&A professionals and company executives.
Registration: Virginia Bio Members receive 10%off registration! Please contact us for discount details and click here to register.

NOVEMBER 12
Event: Virginia Bio Commercialization Luncheon - November 2015
Where: Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, November 12, 11:30am - 1:30pm
Details: Family Funds investing in innovative biomedical companies and nonprofits.
The family fund has emerged as an important new source of capital to propel bioscience innovation and commercialization. Using wealth accumulated for making big impact, family funds invest in small and emerging companies, and make venture philanthropy investment type donations to nonprofits doing important focused work.
Registration:Click here to register.
Sponsors: Greater Richmond Partnership, VCU Innovation Gateway, We Work For Health and the Virginia Biotechnology Research Park

NOVEMBER 18
Event: TEDMEDLive Streaming
Where: Live Streaming
When: Wednesday, November 18
Details: Due to an exciting partnership with TEDMED and Virginia Bio, TEDMED would like to invite you to join in on this year's event where we will Unlock Imagination in the service of Health and Medicine. We encourage you to convene and share in free online access to TEDMEDLive Streaming 2015, comprising of more than 70 talks from transformative thinkers in health and medicine.
Registration:Click here for additional information.

ABOUT VIRGINIA BIO
Virginia Bio, was formed in 1992 and incorporated in the Commonwealth of Virginia as a non-profit association. The purpose of the Association is to promote the biotechnology industry in Virginia, expand the knowledge and expertise of Virginia's businesses concerning biotechnology through seminars, educational publications and other means, to enhance public awareness of the biotechnology industry in Virginia and the scientific, economic and other benefits it provides, and to represent the interests of the biotechnology industry in Virginia before federal, state and local legislators and regulators. We provide a forum for members and their guests to get to know each other and the many bioscience companies operating today in Virginia and serving our biotech community. We coordinate information among the many agencies and organizations interested in biotechnology.

To learn more about Virginia Bio and how you can get involved, Click Here

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 


 


This is the E-newsletter of Virginia Bio, a non-profit organization dedicated to supporting the Life Sciences community in the Commonwealth of Virginia. New subscribers can join at our website, www.vabio.org. @@unsubscribe_url@


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This email was sent to '@@email@@' from Virginia Bio. If you wish to stop receiving email from us, you can remove yourself by clicking here.
In order to continue receiving emails from Virginia Bio, please add VABIOConnections@vabio.org to your safe sender list.
more Events

12/8/2016
Virginia Bioscience Commercialization Luncheon- December 2016

12/12/2016 » 12/14/2016
ISBioTech 4th Fall Meeting

Premium Members

Membership Software Powered by YourMembership  ::  Legal